



Drug induced cardiotoxicity have emerged as an important factor for developing cardiovascular 
complications. Present day therapeutics for various lifestyle diseases including cancer, diabetes and 
obesity are reported to have cardiotoxic side effects and require urgent attention of the scientific 
community. Use of natural bioactive compounds having cardioprotective properties for 
supplementing cardiotoxic therapies holds a great potential in this regard. This will improve the 
cardiac health without compromising the therapeutic efficiency of the drugs. With this in mind, the 
present study was designed to analyze the effects of Curcumin, polyphenol derived from Curcuma 
longa and well-known for broad range of protective effects, in drug induced cardiotoxicity. Two 
different classes of drugs with known cardiotoxicity were selected for the study with applications 
in cardiac (hypotension) and non-cardiac (cancer) conditions, namely Levophed (or 
Norepinephrine or NE) and Doxorubicin, respectively.  
Cardiotoxic stress induced by these drugs was firstly confirmed on cardiomyoblasts in 
concentration and time dependent manner by various cell viability assays individually. The effects 
of Curcumin on Doxorubicin and Levophed induced cardiotoxicity were then studied by various 
microscopic, molecular, biochemical and immunological assays. In silico molecular docking 
studies were conducted for Doxorubicin, NE and Curcumin with signaling molecules reported in 
different cardiac stresses to derive the possible signaling involved in Curcumin mediated effects. 
Gene expression analysis was done at transcriptomic and proteomic levels for various cell survival 
and death biomarkers in drug induced in vitro and in vivo models treated with Curcumin at different 
time points.  
We observed that both the selected drugs results in dose mediated stress responses in 
cardiomyoblasts and Curcumin significantly resisted and prevented these effects in a mode 
dependent manner. The in vitro findings were validated in in vivo models and possible signaling 
mechanism of Curcumin mediated effects were derived.  
In conclusion, Curcumin holds a great potential for reducing drug induced cardiotoxicity when 
supplemented with the ongoing therapies having cardiotoxic effects.  
 
